DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more
Drugs by Name Drugs by Condition Drugs by Category Most Searched Ratings/Reviews Active Ingred's Alerts Adverse Events

Hexalen (Altretamine) - Summary

Hexalen Rx
Summary Description Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Clinical Pharmacology Other Rx Information Active Ingredients
 

Hexalen News
News in Media Published Studies Curr't Clinical Trials

-- advertisement --

WARNINGS

  1. HEXALEN® capsules should only be given under the supervision of a physician experienced in the use of antineoplastic agents.
  2. Peripheral blood counts should be monitored at least monthly, prior to the initiation of each course of HEXALEN® capsules, and as clinically indicated (see Adverse Reactions).
  3. Because of the possibility of HEXALEN® capsules-related neurotoxicity, neurologic examination should be performed regularly during HEXALEN® capsules administration (see Adverse Reactions).
 

HEXALEN SUMMARY

HEXALEN®
(ALTRETAMINE) CAPSULES 50 mg

HEXALEN (altretamine), is a synthetic cytotoxic antineoplastic s-triazine derivative. HEXALEN capsules contain 50 mg of altretamine for oral administration. Inert ingredients include lactose, anhydrous and calcium stearate.

HEXALEN is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.

HEXALEN NEWS HIGHLIGHTS

Media Articles Related to Hexalen (Altretamine)

FDA Warns LabCorp About Illegal Sales Of Ovarian Cancer Test
Source: Medical Devices / Diagnostics News From Medical News Today [2008.10.09]

FDA Says Ovarian Cancer Test is Marketed Illegally
Source: MedPageToday.com - medical news plus CME for physicians [2008.10.09]

Researchers ID Ovarian Cancer Biomarker
Source: MedicineNet Ovarian Cancer Specialty [2008.09.24]

Drug Combo Fights Recurrent Ovarian Cancer Cell Growth
Source: MedicineNet Cervical Cancer Specialty [2008.09.19]

Ovarian Cancer
Source: MedicineNet Cancer Causes Specialty [2008.07.10]

more>>

Published Studies Related to Hexalen (Altretamine)

The bioavailability of three altretamine formulations. [1989.12.15]

Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group. [2004.03]

Oral altretamine used as salvage therapy in recurrent ovarian cancer. [2004.01]

Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study. [2003.02]

A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer. [2001.08]

more>>

Clinical Trials Related to Hexalen (Altretamine)

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer [Completed]

more>>
Page last updated: 2008-10-09

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008